Mark A. West
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 18
- Drug Transport and Resistance Mechanisms 17
-
- Pharmacogenetics and Drug Metabolism 7
- Co-authors
- Manthena V. S. Varma (11 shared papers)Chester Costales (8 shared papers)Bo Feng (6 shared papers)Sarah Lazzaro (7 shared papers)Larry M. Tremaine (3 shared papers)Yi‐An Bi (6 shared papers)Jennifer L. Liras (4 shared papers)Emi Kimoto (3 shared papers)
- Journals
- Drug Metabolism and Disposition (5 papers)Clinical Pharmacology & Therapeutics (4 papers)Journal of Pharmaceutical Sciences (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Frontiers in Pharmacology (1 paper)
- Partner nations
- United StatesFinlandChina
In The Last Decade
Mark A. West
22 papers receiving 446 citations
Peers
Comparison fields: 5 of 74
- Pharmacology 123
- Oncology 298
- Pediatrics, Perinatology and Child Health 129
- Clinical Biochemistry 19
- Environmental Chemistry 27
Countries citing papers authored by Mark A. West
This map shows the geographic impact of Mark A. West's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. West with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. West more than expected).
Fields of papers citing papers by Mark A. West
This network shows the impact of papers produced by Mark A. West. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. West. The network helps show where Mark A. West may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. West, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 68 | |
| 2 | 2019 | 61 | |
| 3 | 2021 | 40 | |
| 4 | 2020 | 37 | |
| 5 | 2021 | 34 | |
| 6 | 2013 | 33 | |
| 7 | 2024 | 31 | |
| 8 | 2019 | 30 | |
| 9 | 2013 | 30 | |
| 10 | 2018 | 27 | |
| 11 | 2021 | 16 | |
| 12 | 2019 | 12 | |
| 13 | 1998 | 8 | |
| 14 | 2021 | 7 | |
| 15 | 2023 | 5 | |
| 16 | 2024 | 5 | |
| 17 | 2013 | 5 | |
| 18 | 2023 | 3 | |
| 19 | 2025 | 2 | |
| 20 | 2025 | 1 |
About Mark A. West
Mark A. West is a scholar working on Oncology, Pharmacology, Pediatrics, Perinatology and Child Health, Epidemiology and Infectious Diseases, having authored 23 papers that have together received 457 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (17 papers), Pharmacogenetics and Drug Metabolism (7 papers), Pharmacological Effects and Toxicity Studies (5 papers), Liver Disease Diagnosis and Treatment (4 papers), Folate and B Vitamins Research (2 papers), Metabolism and Genetic Disorders (2 papers), Nanoparticle-Based Drug Delivery (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Pharmacology (123 citations), Oncology (298 citations), Pediatrics, Perinatology and Child Health (129 citations), Clinical Biochemistry (19 citations) and Environmental Chemistry (27 citations). Mark A. West has collaborated with scholars based in United States, Finland and China. Frequent co-authors include Manthena V. S. Varma, Chester Costales, Bo Feng, Sarah Lazzaro, Larry M. Tremaine, Yi‐An Bi, Jennifer L. Liras, Emi Kimoto, Nandini C. Patel and Travis T. Wager. Their work appears in journals such as Drug Metabolism and Disposition, Clinical Pharmacology & Therapeutics, Journal of Pharmaceutical Sciences, Journal of Pharmacology and Experimental Therapeutics and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.